Fluent Lyra Indica Dominant Flower

(2 customer reviews)


Flavorful Indica with relaxed bodily effects

While the specific ratio of Sativa to Indica technically falls within the ‘hybrid’ label, patients generally agree the effects fall mostly on the Indica side. Derived from the West Coast classic Sweet Kush, Lyra has a particularly sweet flavor and aroma with hints of earthy and fruity tones. The immediate effect is cerebral, but that quickly fades into bodily deep relaxation. The effects are described as creativity inducing while delivering a healthy dose of euphoria.

Sold By: Fluent

Categories: Flower/Dry Herb, Indica Dominant

Out of stock

2 reviews for Fluent Lyra Indica Dominant Flower

  1. Eric

    Not very impressed with the Lyra.
    I bought three pre-rolls but they did not burn very well. Really bad runs.
    Second off once I moved it to my bong to smoke I found that it gave me much more confusion and problems not functioning well, versus it’s having a less positive effect on my symptoms.

  2. KGreenWay

    This flower has an amazing ability to get myself to a point of being very euphoric and even most times to the point of loss of time and other basic functions. This is a very good remedy should you find that your time is going by very slow. Hours go by while I think it has been less than one hour elapsed.

Add a review

Your email address will not be published. Required fields are marked *

Product Description

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, reassess symptoms.

If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2.

Cash & CanPay Accepted

Lyra is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Lyra;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.